Chloramphenicol-Resistant Split CAT Protein for Rich-Media PPI Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing split DHFR systems for detecting protein-protein interactions (PPI) require restrictive media conditions and prolonged growth times due to their reliance on bacteriostatic antibiotics like trimethoprim, complicating the quantification and analysis of PPI events.
Innovation Solution
A novel split chloramphenicol acetyltransferase (CAT) system that allows bacterial growth in rich media by resisting chloramphenicol, enabling rapid and efficient detection of PPIs through bacterial survival in the presence of the antibiotic.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If split DHFR system is used for detecting PPI, then antibiotic resistance function is achieved, but restrictive media conditions and prolonged growth times are required
Solution Approach 1:
The patent changes the antibiotic resistance mechanism from DHFR-based (requiring restrictive media) to CAT-based (compatible with rich media). By substituting the enzyme system and resistance mechanism, the growth conditions parameter is optimized to allow rapid growth in rich media while maintaining reliable antibiotic resistance selection.
Solution Approach 2:
The patent converts the previously harmful effect of requiring restrictive media into a benefit by using CAT-mediated chloramphenicol resistance that works in rich media. The split CAT system allows cells to thrive in nutrient-rich conditions while still providing reliable selection pressure through chloramphenicol resistance, turning the limitation into an advantage for high-throughput screening.
2Reliability
If split DHFR system is used for detecting PPI, then selection capability is achieved, but complex assay conditions are required
Solution Approach 1:
The patent simplifies assay conditions by changing from DHFR-based selection (requiring metabolite supplementation and restrictive media) to CAT-based selection (using standard rich media and chloramphenicol). This parameter change eliminates the need for complex media preparation and metabolic supplementation, reducing overall assay complexity while maintaining selection capability.
Solution Approach 2:
The patent extracts and removes the complex metabolic requirements associated with DHFR systems. By using CAT instead, the system eliminates the need for thymidine or other metabolite supplementation, removing the cumbersome assay conditions while preserving the essential selection function for PPI detection.
3Productivity
If split CAT system is used, then rapid growth in rich media is achieved, but new construct design is required
Solution Approach 1:
The patent divides the CAT enzyme into two functional fragments (N-terminal and C-terminal) that can independently associate only when brought together by PPI. This segmentation enables the creation of modular construct designs where each fragment can be independently optimized and combined with different bait or prey proteins, facilitating rapid growth screening while maintaining design flexibility.
Solution Approach 2:
The split CAT system provides universal applicability across different PPI detection needs. The modular fragment design allows the same CAT-based selection mechanism to be applied to various protein pairs and experimental conditions, enabling rapid growth in rich media as a universal readout for PPI while simplifying construct design through standardized fragment libraries.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates high-throughput screening of PPIs in various cell types and species by shortening experimental times and enhancing growth rates, allowing for precise quantification and analysis of protein interactions.
Implementation Method 1
the N-terminal fragment is capable of associating with the C-terminal fragment to generate an active CAT that is capable of acetylating chloramphenicol
Data Source
AI summary
A system for expressing a chloramphenicol split protein is disclosed. Uses thereof are also disclosed.